Movement Alert|Everpure Rises 5.15% in Regular Trading, Multiple Institutional Upgrades and Earnings Expectations Fuel Momentum

Market Focus
Yesterday

On August 25, Everpure rose 5.15% in regular trading, trading at $105.79 USD/share, with turnover of $13.155 million. The rally was driven by a wave of institutional upgrades and optimistic expectations ahead of the company's fiscal Q2 earnings report scheduled for August 26 after market close.

On the news front, multiple Wall Street firms recently raised their ratings and price targets on Everpure. Wedbush raised its price target to $127 from $105 while maintaining an Outperform rating, expecting a beat-and-raise quarter supported by stronger pricing and favorable product mix. Susquehanna upgraded the stock from Neutral to Positive with a target price increase to $120 from $85, citing the company's ability to address hyperscale data center storage needs. Morgan Stanley upgraded to Overweight from Equalweight, adjusting its target to $108 from $87.

Market consensus expects fiscal Q2 revenue of approximately $11 billion, representing roughly 30% year-over-year growth, with adjusted EPS of $0.58, up nearly 50%. Additionally, the company earlier secured a second design and supply contract with a top-five hyperscaler, expected to contribute meaningfully to revenue starting in fiscal 2028.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10